Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Amarin Stock Was a Winner Today

TheMotleyFool

0 0

Shares of Amarin (NASDAQ: AMRN) closed 3.9% higher on Tuesday, after there was some good news from across the Atlantic Ocean regarding the only product the company has on the market.

That drug, Vascepa, is used to reduce the risk of stroke and heart attacks in patients taking statins for cardiovascular conditions. On Tuesday, the European Commission (EC), the executive branch of the European Union, approved the medication, which is sold under the brand name Vazkepa in that market.

Image source: Getty Images.

Source Fool.com

Like: 0

AMRN

Share